CASP4 and colitis: The divergent regulation of CASP4 and CASP5 supports the view that these genes are non-redundant and puts into question the validity of extrapolating results from murine colitis models to develop human therapeutics, particularly as the constitutive expression of caspase-4 cannot be replicated in this model.